Denton Sheila A. — SEC insider filings
SEC reporting owner CIK 1995298. 19 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2023-10-04 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 13 filings — 28,181 shares, $2,141,982 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 9,574 shares @ $74.07 ($709,146) in INCYTE CORP, filed 2025-02-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INCYTE CORP (INCY) | EVP & General Counsel | 17 | — | 16 legs · 28,181 sh · $2,141,982 | 37 |
| MiniMed Group, Inc. (MMED) | SVP, Gen. Counsel & Corp. Sec. | 2 | — | — | 1 |
Insider filings — Denton Sheila A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 58,939 @ $0 | EDGAR |
| 2026-10-01 | 3 | MiniMed Group, Inc. (MMED) | Holdings only — no transactions reported | EDGAR |
| 2025-11-19 | 4 | INCYTE CORP (INCY) | Option exercise (M): 278 @ $64.25 · Sale (S): 278 @ $104.36 · Option exercise (M): 278 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | INCYTE CORP (INCY) | Option exercise (M): 598 @ $58.06 · Sale (S): 598 @ $101.36 · Option exercise (M): 598 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | INCYTE CORP (INCY) | Option exercise (M): 277 @ $64.25 · Sale (S): 277 @ $85.13 · Option exercise (M): 277 (derivative) @ $0 | EDGAR |
| 2025-10-06 | 4 | INCYTE CORP (INCY) | Option exercise (M): 599 @ $58.06 · Sale (S): 599 @ $87.65 · Tax withholding (F): 3,130 @ $86.28 · Sale (S): 3,501 @ $85.54 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4 | INCYTE CORP (INCY) | Option exercise (M): 278 @ $64.25 · Sale (S): 278 @ $83.15 · Option exercise (M): 278 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | INCYTE CORP (INCY) | Option exercise (M): 598 @ $58.06 · Sale (S): 598 @ $84.97 · Option exercise (M): 598 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | INCYTE CORP (INCY) | Option exercise (M): 277 @ $64.25 · Sale (S): 277 @ $86.81 · Option exercise (M): 277 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | INCYTE CORP (INCY) | Option exercise (M): 598 @ $58.06 · Sale (S): 598 @ $75.77 · Option exercise (M): 598 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | INCYTE CORP (INCY) | Option exercise (M): 3,330 @ $64.25 · Sale (S): 3,330 @ $69.86 · Tax withholding (F): 703 @ $68.25 · Grant/award (A): 8,184 @ $0 · Sale (S): 785 @ $68.36 · Option exercise (M): 3,330 (derivative) @ $0 · +2 more | EDGAR |
| 2025-07-07 | 4 | INCYTE CORP (INCY) | Option exercise (M): 599 @ $58.06 · Sale (S): 599 @ $68.61 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | INCYTE CORP (INCY) | Option exercise (M): 1,795 @ $58.06 · Sale (S): 1,795 @ $68 · Option exercise (M): 1,795 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | INCYTE CORP (INCY) | Option exercise (M): 599 @ $58.06 · Sale (S): 599 @ $69.99 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | INCYTE CORP (INCY) | Option exercise (M): 9,574 @ $58.06 · Sale (S): 9,574 @ $74.07 · Sale (S): 4,495 @ $74.08 · Option exercise (M): 9,574 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | INCYTE CORP (INCY) | Grant/award (A): 12,086 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 2,136 @ $67.63 | EDGAR |
| 2024-07-17 | 4 | INCYTE CORP (INCY) | Grant/award (A): 5,955 @ $0 · Grant/award (A): 13,323 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | INCYTE CORP (INCY) | Grant/award (A): 26,524 @ $0 · Grant/award (A): 28,725 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1995298 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs